[Recommendations About Multiple Sclerosis Management During Pregnancy, Partum and Post-Partum: Consensus Position of The Portuguese Multiple Sclerosis Study Group and The Portuguese Society of Obstetrics and Maternal-Fetal Medicine].

Multiple sclerosis typically affects young women of reproductive age. Therefore, all healthcare providers involved in the follow-up of multiple sclerosis patients must be prepared to discuss pregnancy and breastfeeding issues, and provide the best possible counselling. However, there are still many doubts and heterogeneous clinical approaches partly due to the lack of consensus and guidelines. Concerning the handling of disease modifying therapies during pregnancy and the postpartum period, uncertainties have been complicated by the increase in recent years of the number of available treatments. This article aims to present the state-of-the-art and provide guidance based on the best level of available evidence and expert opinion regarding the management of multiple sclerosis patients at different stages: pregnancy planning, pregnancy, partum, and the postpartum period.

[1]  Jeffrey A. Cohen,et al.  Applying the 2017 McDonald diagnostic criteria for multiple sclerosis – Authors' reply , 2018, The Lancet Neurology.

[2]  D. Ogunyemi,et al.  Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[3]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[4]  M. Filippi,et al.  Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning , 2016, Multiple sclerosis.

[5]  M. Trojano,et al.  History of multiple sclerosis in 2 successive pregnancies , 2016, Neurology.

[6]  S. Tavakolpour,et al.  New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy , 2016, Scandinavian journal of immunology.

[7]  M. Wenten,et al.  Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study , 2016, BMC Neurology.

[8]  Shin C. Beh,et al.  Neurotherapeutic Strategies for Multiple Sclerosis. , 2016, Neurologic clinics.

[9]  A. Ascherio,et al.  Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort. , 2016, JAMA neurology.

[10]  A. Ascherio,et al.  Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update , 2016, Seminars in Neurology.

[11]  A. Langer-Gould,et al.  Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility , 2016, PloS one.

[12]  P. Coyle Management of women with multiple sclerosis through pregnancy and after childbirth , 2016, Therapeutic advances in neurological disorders.

[13]  C. Binns,et al.  The Long-Term Public Health Benefits of Breastfeeding , 2016, Asia-Pacific journal of public health.

[14]  C. Pozzilli,et al.  Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis , 2015, Multiple sclerosis.

[15]  M. Magyari Role of socio‐economic and reproductive factors in the risk of multiple sclerosis , 2015, Acta neurologica Scandinavica.

[16]  S. Vukusic,et al.  Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis , 2015, Multiple sclerosis.

[17]  S. Vukusic,et al.  Multiple sclerosis and pregnancy in the 'treatment era' , 2015, Nature Reviews Neurology.

[18]  P. Touraine,et al.  Fecundity in women with multiple sclerosis: an observational mono-centric study , 2015, Journal of Neurology.

[19]  G. Koren,et al.  Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study , 2015, Multiple sclerosis.

[20]  T. Kauko,et al.  Multiple sclerosis and vitamin D during pregnancy and lactation , 2015, Acta neurologica Scandinavica.

[21]  R. Gold,et al.  Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis , 2015, Multiple sclerosis.

[22]  P. Mccombe,et al.  Multiparity in women with multiple sclerosis causes less long-term disability: No , 2014, Multiple sclerosis.

[23]  J. De Keyser,et al.  Multiparity in women with multiple sclerosis causes less long-term disability: Yes , 2014, Multiple sclerosis.

[24]  M. Hutchinson Multiparity in women with multiple sclerosis causes less long-term disability: Commentary , 2014, Multiple sclerosis.

[25]  F. Salvi,et al.  Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis. , 2014, Fertility and sterility.

[26]  R. Gold,et al.  Natalizumab use during the third trimester of pregnancy. , 2014, JAMA neurology.

[27]  J. Lechner-Scott,et al.  Predictors and dynamics of postpartum relapses in women with multiple sclerosis , 2014, Multiple sclerosis.

[28]  T. Olsson,et al.  Reverse causality behind the association between reproductive history and MS , 2014, Multiple sclerosis.

[29]  Yinshan Zhao,et al.  Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs , 2014, CNS Drugs.

[30]  R. Bove,et al.  Neuroradiology in Women of Childbearing Age , 2014, Continuum.

[31]  A. Synnes,et al.  A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis , 2014, CNS Drugs.

[32]  C. Pozzilli,et al.  Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  J. Correale,et al.  Artificial reproductive techniques in multiple sclerosis. , 2013, Clinical immunology.

[34]  A. Langer-Gould,et al.  Effects of pregnancy and breastfeeding on the multiple sclerosis disease course. , 2013, Clinical immunology.

[35]  C. Wolfson,et al.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review , 2013, BMC Neurology.

[36]  C. Kolb,et al.  Multiple sclerosis and pregnancy: therapeutic considerations , 2013, Journal of Neurology.

[37]  A. Sadovnick,et al.  Reproductive decision making after the diagnosis of multiple sclerosis (MS) , 2013, Multiple sclerosis.

[38]  Y. Fragoso,et al.  The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis , 2013, Clinical Neurology and Neurosurgery.

[39]  B. Cree Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis , 2013, Multiple sclerosis.

[40]  C. Pozzilli,et al.  Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study , 2012, BMC Neurology.

[41]  J. Lünemann,et al.  The initiation and prevention of multiple sclerosis , 2012, Nature Reviews Neurology.

[42]  J. Correale,et al.  Increase in multiple sclerosis activity after assisted reproduction technology , 2012, Annals of neurology.

[43]  V. Davoudi,et al.  Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy , 2012, European Neurology.

[44]  R. Gold,et al.  Multiple sclerosis and pregnancy: experience from a nationwide database in Germany , 2012, Therapeutic advances in neurological disorders.

[45]  R. Pedrosa,et al.  Oral contraceptive use and clinical outcomes in patients with multiple sclerosis , 2012, Journal of the Neurological Sciences.

[46]  M. Clanet,et al.  Increased risk of multiple sclerosis relapse after in vitro fertilisation , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  G. Giovannoni,et al.  Breastfeeding and multiple sclerosis relapses: a meta-analysis , 2012, Journal of Neurology.

[48]  K. Dear,et al.  Offspring number, pregnancy, and risk of a first clinical demyelinating event , 2012, Neurology.

[49]  D. Pelletier,et al.  Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort , 2012, Multiple sclerosis.

[50]  C. Pozzilli,et al.  Breastfeeding is not related to postpartum relapses in multiple sclerosis , 2011, Neurology.

[51]  A. Synnes,et al.  Neonatal and Delivery Outcomes in Women with Multiple Sclerosis , 2011, Annals of neurology.

[52]  A. Finkelsztejn,et al.  What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta‐analysis of the literature , 2011, BJOG : an international journal of obstetrics and gynaecology.

[53]  G. Ebers,et al.  Congenital Abnormalities and Multiple Sclerosis , 2010, BMC neurology.

[54]  M. Boggild,et al.  Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes , 2010, Journal of Neurology.

[55]  L. Airas,et al.  Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland , 2010, Multiple sclerosis.

[56]  A. Sadovnick,et al.  No Effect of Parental Age on Risk of Multiple Sclerosis: A Population-Based Study , 2009, Neuroepidemiology.

[57]  S. Vukusic,et al.  The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement , 2009, Journal of the Neurological Sciences.

[58]  T. Trikalinos,et al.  A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. , 2009, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[59]  W. Engel,et al.  INTRAVENOUS IMMUNOGLOBULIN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A DOSE-FINDING TRIAL , 2009, Neurology.

[60]  R. Gold,et al.  Increase in Relapse Rate during Assisted Reproduction Technique in Patients with Multiple Sclerosis , 2008, European Neurology.

[61]  P. Butow,et al.  The motherhood choice: Themes arising in the decision-making process for women with multiple sclerosis , 2008, Multiple sclerosis.

[62]  P. Butow,et al.  The motherhood choice: a decision aid for women with multiple sclerosis. , 2008, Patient education and counseling.

[63]  F. Fazekas,et al.  Intravenous immunoglobulin in MS: Promise or failure? , 2007, Journal of the Neurological Sciences.

[64]  O. Hommes,et al.  A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis , 2007, Multiple sclerosis.

[65]  U. Zettl,et al.  Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis , 2006, Journal of Neurology.

[66]  N. Gilhus,et al.  Planned vaginal births in women with multiple sclerosis: delivery and birth outcome , 2006, Acta neurologica Scandinavica. Supplementum.

[67]  E. Leray,et al.  Increase in multiple sclerosis relapse rate following in vitro fertilization , 2006, Neurology.

[68]  Miguel A Hernán,et al.  Recent use of oral contraceptives and the risk of multiple sclerosis. , 2005, Archives of neurology.

[69]  P. Vermersch,et al.  Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis , 2004, Multiple sclerosis.

[70]  A. Achiron,et al.  Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis , 2004, Journal of Neurology.

[71]  P. Ragonese,et al.  The relapse rate of multiple sclerosis changes during pregnancy: a cohort study , 2004, Acta neurologica Scandinavica.

[72]  P. Sørensen Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials , 2003, Neurological Sciences.

[73]  Seth E. Bouvier,et al.  Treatment of multiple sclerosis with the pregnancy hormone estriol , 2002, Annals of neurology.

[74]  H. Ford,et al.  Multiple sclerosis and pregnancy , 2002, Postgraduate medical journal.

[75]  B. Mueller,et al.  Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. , 2002, American journal of obstetrics and gynecology.

[76]  D Spiegelman,et al.  Oral contraceptives and the incidence of multiple sclerosis , 2000, Neurology.

[77]  M. Hutchinson,et al.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. , 1999, The New England journal of medicine.

[78]  G. Comi Early treatment , 2006, Neurological Sciences.